Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?
about
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysisSurveillance for hepatocellular carcinoma.Hepatocellular carcinoma: a reviewAn assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.Racial, social, and clinical determinants of hepatocellular carcinoma surveillanceRole of surveillance in prevention of hepatocellular carcinoma.Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.Accuracy of ultrasound and noninvasive markers of fibrosis to identify patients with cirrhosisHBV Outreach Programs Significantly Increase Knowledge and Vaccination Rates Among Asian Pacific Islanders.Role functioning is associated with survival in patients with hepatocellular carcinoma.The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma.Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinomaHepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalMeta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States.Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversiesIncreased sialylation of site specific O-glycoforms of hemopexin in liver disease.Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?A primer on effectiveness and efficacy trialsThe changing landscape of hepatocellular carcinoma: etiology, genetics, and therapyFactors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma.MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue.Utility and cost-effectiveness of screening for hepatocellular carcinoma in a resource-limited setting.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma.Screening process failures for hepatocellular carcinoma.Diagnostic delays are common among patients with hepatocellular carcinoma.Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array.The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt SignalingHepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach.On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.Proposal of objective morphological classification system for hepatocellular carcinoma using preoperative multiphase computed tomography.
P2860
Q21144594-8635F8B6-7DED-446C-8BA5-7F35D871C663Q27690269-A32BBCB8-A3F5-4186-83D4-47D9A2032919Q28069290-2B6D2792-0F7B-407D-95E6-FE67F2CD2753Q33436257-4A76087D-B294-4D7F-98A5-DB8FCA4CE02DQ33648955-FFFE6DD4-86D9-48ED-91CE-16B8BC7A199AQ34808945-4012454F-529A-48BB-B26F-8A3F80D71507Q34826014-99EEA945-258F-4200-A690-04B780D24F17Q34902635-5637120F-84D5-4EF5-92B6-8832318C8E34Q35685126-42A2073F-7C43-449F-BD87-899A7AE4214DQ35689186-7111DAD6-2AD4-48D7-91F0-AED591260EF7Q35738710-9FEE9B41-F80B-4577-B445-A0060EE1D7B4Q35742449-46445457-4E79-4B92-A9A3-8480DAC42A75Q36053838-7992A318-481B-4162-9BFD-4EF3F960084CQ36175747-625C9256-A500-4100-BC85-07C82E63574DQ36199751-A6FD24F9-D80A-469B-82E0-D6DA62447C30Q36404471-A818F99B-704F-4E62-9CF8-73B81F3F6AFBQ36762656-3FDD1A7E-C6C0-4A4E-8F80-39A59724F1BDQ37184472-87BD36D0-08F6-4E47-9B59-15024A51AD22Q37266376-BF1CEEB0-8F18-4154-8CB5-9E1B78B2E974Q37278723-F63AFBCA-75C7-4E1F-BD4C-13B9F9BE5957Q37408912-3D10A459-2328-4AE0-A821-2B4BF649B89AQ37549837-D190EDB8-0B77-4015-B4C2-C47FB8FDAFECQ37606028-96636241-5062-4928-96E8-8AA66B378330Q37684651-EA62737B-F614-41A8-828A-FD37BC156D2AQ37706507-6AF714B1-FC2C-492E-9D76-0721445762ACQ38387249-A09CCB96-04BF-42D6-821A-A913B586CD96Q38611765-AA05BD80-64E8-48B0-ADA1-28C8C48504E4Q38992897-942E5EC5-95A2-4CE7-8D63-C4F182C1C4D3Q39197775-6081BA6F-F37F-4653-BECF-976488E72E8DQ40135381-F94D285E-C066-4B2E-B5CB-CF138B3B40CFQ40136684-B0441D1B-C6F1-4CB4-B5AD-E25DF28A5140Q40176654-47B60647-95CF-433C-98B5-C5FED174B65BQ40279432-0B2B6BBB-02A0-4250-8D4E-E3B761FDC0D5Q40442376-EE22F4AC-B31E-47B2-AADD-44B5726C34E3Q40468745-E9109BF8-9D03-4BE5-B379-6AD94A6370DCQ40928864-3E0B9A32-6A5C-46B5-B7F1-FFB6EB1F8785Q41573243-DC19A7D8-6619-47DC-8B19-EBD602D20B3AQ42228465-8D5535D3-5A36-42FE-A66F-03D55F9422E2Q42262667-9AD76B05-8152-4696-8D71-04494979A59DQ43836606-4C46A3DA-65F4-43E2-8AF0-B904F62D5711
P2860
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Detection of hepatocellular ca ...... : where did surveillance fail?
@en
type
label
Detection of hepatocellular ca ...... : where did surveillance fail?
@en
prefLabel
Detection of hepatocellular ca ...... : where did surveillance fail?
@en
P2093
P2860
P356
P1476
Detection of hepatocellular ca ...... : where did surveillance fail?
@en
P2093
Adam C Yopp
Amit G Singal
Anna S Lok
Beverley Adams-Huet
Jorge A Marrero
Mahendra Nehra
William M Lee
P2860
P304
P356
10.1038/AJG.2012.449
P407
P50
P577
2013-01-22T00:00:00Z